Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HLX07 plus chemotherapy in advanced solid tumors (Ib/II, China)
CTR20180863Phase 2Completed
- Sponsor
- Henlius
- Start
- Jul 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of pimurutamab in Nonhematologic neoplasms, cancer, sponsored by Henlius. Started Jul 2018; status: completed.
02
Drugs
pimurutamab
03
Conditions
Nonhematologic neoplasmscancer
Beyond the preview
Go deeper on CTR20180863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180863.